Arrowhead Pharmaceuticals ARWR
$ 18.49
1.15%
Quarterly report 2024-Q2
added 08-08-2024
Arrowhead Pharmaceuticals EV/EBITDA Ratio 2011-2024 | ARWR
Annual EV/EBITDA Ratio Arrowhead Pharmaceuticals
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
-30.8 | -64.5 | 53.9 | -19.8 | -7.66 | -3.6 | -2.29 | -3.69 | -6.91 | -1.12 | -3.17 |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
53.9 | -64.5 | -8.15 |